Loading...

Fixation Buffer Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL DKK351
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  2. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  3. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  4. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  5. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  6. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  7. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  8. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  9. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  10. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  11. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  12. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  13. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  14. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  15. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  16. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  17. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  18. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  19. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  20. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  21. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  22. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  23. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  24. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  25. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  26. Chan L, et al. 2022. Cells. 12: . PubMed
  27. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  28. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  29. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  30. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  31. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  32. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  33. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  34. Zander R, et al. 2022. Immunity. 55:475. PubMed
  35. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  36. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  37. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  38. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  39. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  40. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  41. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  42. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  43. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  44. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  45. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  46. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  47. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  48. Wang H, et al. 2023. Nature. 615:339. PubMed
  49. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  50. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  51. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  52. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  53. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  54. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  55. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  56. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  57. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  58. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  59. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  60. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  61. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  62. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  63. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  64. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  65. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  66. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  67. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  68. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  69. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  70. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  71. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  72. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  73. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  74. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  75. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  76. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  77. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  78. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  79. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  80. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  81. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  82. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  83. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  84. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  85. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  86. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  87. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  88. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  89. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  90. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  91. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  92. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  93. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  94. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  95. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  96. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  97. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  98. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  99. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  100. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  101. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  102. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  103. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  104. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  105. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  106. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  107. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  108. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  109. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  110. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  111. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  112. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  113. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  114. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  115. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  116. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  117. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  118. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  119. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  120. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  121. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  122. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  123. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  124. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  125. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  126. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  127. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  128. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  129. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  130. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  131. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  132. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  133. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  134. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  135. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  136. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  137. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  138. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  139. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  140. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  141. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  142. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  143. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  144. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  145. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  146. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  147. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  148. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  149. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  150. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  151. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  152. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  153. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  154. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  155. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  156. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  157. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  158. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  159. Ma K, et al. 2022. iScience. 25:104347. PubMed
  160. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  161. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  162. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  163. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  164. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  165. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  166. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  167. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  168. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  169. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  170. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  171. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  172. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  173. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  174. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  175. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  176. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  177. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  178. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  179. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  180. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  181. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  182. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  186. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  187. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  188. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  189. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  190. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  191. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  192. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  193. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  194. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  195. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  196. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  197. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  198. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  199. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  200. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  201. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  202. Wang X, et al. 2022. Elife. 11:. PubMed
  203. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  204. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  205. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  206. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  207. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  208. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  209. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  210. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  211. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  212. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  213. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  214. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  215. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  216. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  217. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  218. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  219. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  220. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  221. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  222. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  223. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  224. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  225. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  226. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  227. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  228. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  229. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  230. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  231. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  232. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  233. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  234. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  235. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  236. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  237. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  238. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  239. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  240. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  241. Chan L, et al. 2022. Cells. 12: . PubMed
  242. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  243. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  244. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  245. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  246. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  247. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  248. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  249. Zander R, et al. 2022. Immunity. 55:475. PubMed
  250. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  251. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  252. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  253. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  254. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  255. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  256. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  257. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  258. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  259. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  260. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  261. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  262. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  263. Wang H, et al. 2023. Nature. 615:339. PubMed
  264. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  265. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  266. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  267. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  268. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  269. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  270. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  271. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  272. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  273. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  274. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  275. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  276. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  277. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  278. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  279. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  280. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  281. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  282. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  283. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  284. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  285. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  286. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  287. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  288. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  289. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  290. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  291. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  292. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  293. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  294. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  295. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  296. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  297. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  298. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  299. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  300. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  301. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  302. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  303. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  304. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  305. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  306. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  307. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  308. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  309. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  310. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  311. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  312. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  313. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  314. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  315. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  316. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  317. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  318. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  319. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  320. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  321. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  322. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  323. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  324. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  325. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  326. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  327. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  328. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  329. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  330. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  331. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  332. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  333. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  334. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  335. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  336. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  337. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  338. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  339. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  340. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  341. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  342. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  343. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  344. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  345. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  346. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  347. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  348. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  349. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  350. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  351. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  352. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  353. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  354. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  355. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  356. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  357. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  358. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  359. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  360. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  361. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  362. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  363. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  364. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  365. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  366. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  367. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  368. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  369. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  370. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  371. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  372. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  373. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  374. Ma K, et al. 2022. iScience. 25:104347. PubMed
  375. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  376. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  377. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  378. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  379. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  380. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  381. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  382. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  383. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  384. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  385. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  386. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  387. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  388. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  389. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  390. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  391. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  392. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  393. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  394. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  395. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  396. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  397. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  398. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  399. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  400. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  401. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  402. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  403. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  404. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  405. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  406. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  407. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  408. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  409. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  410. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  411. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  412. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  413. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  414. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  415. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  416. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  417. Wang X, et al. 2022. Elife. 11:. PubMed
  418. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  419. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  420. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  421. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  422. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  423. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  424. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  425. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  426. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  427. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  428. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  429. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  430. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 07/25/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL DKK351
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  2. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  3. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  4. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  5. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  6. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  7. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  8. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  9. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  10. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  11. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  12. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  13. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  14. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  15. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  16. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  17. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  18. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  19. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  20. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  21. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  22. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  23. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  24. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  25. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  26. Chan L, et al. 2022. Cells. 12: . PubMed
  27. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  28. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  29. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  30. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  31. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  32. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  33. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  34. Zander R, et al. 2022. Immunity. 55:475. PubMed
  35. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  36. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  37. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  38. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  39. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  40. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  41. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  42. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  43. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  44. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  45. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  46. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  47. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  48. Wang H, et al. 2023. Nature. 615:339. PubMed
  49. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  50. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  51. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  52. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  53. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  54. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  55. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  56. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  57. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  58. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  59. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  60. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  61. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  62. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  63. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  64. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  65. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  66. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  67. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  68. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  69. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  70. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  71. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  72. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  73. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  74. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  75. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  76. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  77. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  78. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  79. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  80. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  81. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  82. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  83. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  84. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  85. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  86. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  87. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  88. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  89. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  90. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  91. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  92. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  93. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  94. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  95. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  96. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  97. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  98. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  99. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  100. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  101. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  102. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  103. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  104. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  105. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  106. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  107. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  108. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  109. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  110. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  111. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  112. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  113. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  114. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  115. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  116. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  117. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  118. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  119. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  120. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  121. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  122. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  123. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  124. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  125. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  126. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  127. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  128. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  129. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  130. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  131. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  132. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  133. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  134. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  135. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  136. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  137. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  138. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  139. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  140. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  141. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  142. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  143. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  144. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  145. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  146. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  147. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  148. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  149. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  150. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  151. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  152. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  153. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  154. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  155. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  156. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  157. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  158. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  159. Ma K, et al. 2022. iScience. 25:104347. PubMed
  160. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  161. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  162. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  163. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  164. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  165. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  166. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  167. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  168. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  169. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  170. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  171. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  172. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  173. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  174. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  175. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  176. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  177. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  178. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  179. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  180. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  181. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  182. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  186. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  187. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  188. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  189. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  190. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  191. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  192. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  193. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  194. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  195. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  196. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  197. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  198. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  199. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  200. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  201. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  202. Wang X, et al. 2022. Elife. 11:. PubMed
  203. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  204. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  205. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  206. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  207. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  208. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  209. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  210. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  211. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  212. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  213. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  214. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  215. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  216. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  217. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  218. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  219. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  220. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  221. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  222. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  223. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  224. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  225. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  226. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  227. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  228. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  229. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  230. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  231. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  232. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  233. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  234. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  235. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  236. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  237. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  238. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  239. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  240. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  241. Chan L, et al. 2022. Cells. 12: . PubMed
  242. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  243. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  244. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  245. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  246. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  247. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  248. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  249. Zander R, et al. 2022. Immunity. 55:475. PubMed
  250. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  251. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  252. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  253. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  254. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  255. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  256. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  257. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  258. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  259. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  260. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  261. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  262. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  263. Wang H, et al. 2023. Nature. 615:339. PubMed
  264. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  265. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  266. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  267. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  268. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  269. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  270. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  271. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  272. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  273. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  274. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  275. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  276. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  277. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  278. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  279. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  280. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  281. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  282. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  283. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  284. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  285. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  286. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  287. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  288. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  289. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  290. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  291. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  292. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  293. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  294. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  295. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  296. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  297. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  298. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  299. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  300. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  301. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  302. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  303. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  304. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  305. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  306. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  307. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  308. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  309. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  310. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  311. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  312. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  313. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  314. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  315. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  316. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  317. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  318. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  319. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  320. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  321. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  322. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  323. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  324. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  325. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  326. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  327. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  328. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  329. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  330. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  331. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  332. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  333. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  334. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  335. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  336. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  337. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  338. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  339. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  340. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  341. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  342. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  343. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  344. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  345. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  346. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  347. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  348. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  349. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  350. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  351. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  352. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  353. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  354. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  355. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  356. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  357. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  358. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  359. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  360. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  361. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  362. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  363. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  364. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  365. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  366. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  367. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  368. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  369. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  370. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  371. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  372. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  373. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  374. Ma K, et al. 2022. iScience. 25:104347. PubMed
  375. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  376. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  377. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  378. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  379. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  380. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  381. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  382. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  383. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  384. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  385. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  386. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  387. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  388. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  389. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  390. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  391. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  392. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  393. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  394. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  395. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  396. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  397. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  398. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  399. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  400. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  401. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  402. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  403. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  404. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  405. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  406. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  407. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  408. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  409. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  410. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  411. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  412. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  413. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  414. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  415. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  416. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  417. Wang X, et al. 2022. Elife. 11:. PubMed
  418. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  419. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  420. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  421. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  422. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  423. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  424. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  425. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  426. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  427. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  428. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  429. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  430. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 4    Revision Date: 07/25/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account